DRF 4367

Drug Profile

DRF 4367

Alternative Names: COX-2 inhibitors - Dr Reddy's Group; Cyclo-oxygenase-2 inhibitors - Dr Reddy's Group

Latest Information Update: 08 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dr Reddys Research Foundation
  • Class Anti-inflammatories; Small molecules
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 16 Apr 2007 No development reported - Preclinical for Inflammation in India (PO)
  • 25 Aug 2003 A preclinical study has been added to the pharmacokinetics section
  • 23 Nov 2000 Dr Reddy's Group is preparing to file an IND for DRF 4367 in the USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top